Benzinga - Tue, 19 Jan 2021 06:26:25 -0400
Benzinga - Thu, 24 Dec 2020 05:48:17 -0400
Benzinga - Wed, 23 Dec 2020 13:02:12 -0400
load more
Sector: Health Care.Industry: Biotechnology
Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.

Earnings

see more
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-02
REV
Q3 2020Est.ActualSurprise
EPS-0.330
REV11.753M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
SRNESorrento Therapeutics4.21%2.7B

Sorrento Therapeutics Company Questions & Answers

Q

How do I buy Sorrento Therapeutics (SRNE) stock?

A

You can purchase shares of Sorrento Therapeutics (NASDAQ: SRNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sorrento Therapeutics's (SRNE) main competitors?

A

Other companies in Sorrento Therapeutics’s space includes: Zentalis Pharmaceuticals (NASDAQ:ZNTL), Karuna Therapeutics (NASDAQ:KRTX) and Replimune Group (NASDAQ:REPL).

Q

What is the target price for Sorrento Therapeutics?

A

The latest price target for Sorrento Therapeutics (NASDAQ: SRNE) was reported by HC Wainwright & Co. on 2020-07-31. The analyst firm set a price target for 30.00 expecting SRNE to rise to within 12 months (a possible 203.03% upside). 3 analyst firms have reported ratings in the last year.

Q

How much is Sorrento Therapeutics (SRNE) stock ?

A

The stock price for Sorrento Therapeutics (NASDAQ: SRNE) is $9.9 last updated Today at 2:36:25 PM.

Q

When is the next Sorrento Therapeutics (SRNE) dividend?

A

There are no upcoming dividends for Sorrento Therapeutics.

Q

When is Sorrento Therapeutics (NASDAQ:SRNE) reporting earnings?

A
Sorrento Therapeutics’s Q4 earnings are confirmed from now on March 2, 2021.
Q

When is the upcoming split for SRNE?

A

There is no upcoming split for Sorrento Therapeutics.